Stock analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for Axsome Therapeutics in a note issued ...
16hon MSN
We recently compiled a list of the 10 AI News Stories That Are Dominating Headlines. In this article, we are going to take a ...
6h
Hosted on MSNCantor Fitzgerald Initiates Coverage of GH Research (GHRS) with Overweight RecommendationFintel reports that on February 13, 2025, Cantor Fitzgerald initiated coverage of GH Research (NasdaqGM:GHRS) with a ...
CVS Health (CVS) stock was upgraded by Cantor Fitzgerald to Overweight after the company posted strong Q4 results earlier in ...
In a report released yesterday, Troy Jensen from Cantor Fitzgerald reiterated a Buy rating on Kornit Digital (KRNT – Research Report), with a ...
Donald Trump's nominees have the vision and real-world skills required to achieve financial success in business and now bring it to the job for the American people.
Cantor Fitzgerald came out and expressed concerns around the Magnificent Seven group, saying the stocks are “vulnerable.” ...
President Donald Trump’s nominee for U.S. Secretary of Commerce, Howard Lutnick, passed a key procedural vote in the Senate on Thursday, clearing the path for his final confirmation vote.
It’s not that the Trump administration is anti-Goldman Sachs, sources say, but rather there just isn’t as much talent to take ...
Gladstone Institutional Advisory LLC trimmed its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 18.9% in the fourth ...
A U.S. Senate committee voted on Wednesday to advance President Donald Trump's nominee Howard Lutnick, billionaire chairman ...
Cantor Fitzgerald raised the firm’s price target on Protolabs (PRLB) to $50 from $40 and keeps an Overweight rating on the shares. Protolabs reported better-than-expected revenue and adjusted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results